Evidence map›Paper›PMID 31009158›Full record

ArticleJournal of thrombosis and haemostasis : JTH2019

Exon 2 skipping eliminates γ-glutamyl carboxylase activity, indicating a partial splicing defect in a patient with vitamin K clotting factor deficiency.

Mark A Rishavy, Kevin W Hallgren, Haitao Zhang, Kurt W Runge, Kathleen L Berkner

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mark A RishavyDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine at CWRU, Cleveland Clinic, Cleveland, Ohio.
Kevin W HallgrenDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine at CWRU, Cleveland Clinic, Cleveland, Ohio.
Haitao ZhangDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine at CWRU, Cleveland Clinic, Cleveland, Ohio.
Kurt W RungeDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine at CWRU, Cleveland Clinic, Cleveland, Ohio.
Kathleen L BerknerDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine at CWRU, Cleveland Clinic, Cleveland, Ohio.
Cleveland Clinic Lerner College of Medicine · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
STRUCTURE/FUNCTION ANALYSIS OF THE GAMMA-CARBOXYLASER01HL055666 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI BERKNER, KATHLEEN LUCILE · 1997 to 2017
$5.4M
Vitamin K Oxidoreductase: Function and PhysiologyR01HL081093 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI BERKNER, KATHLEEN LUCILE · 2008 to 2017
$3.4M
Mechanisms controlling the efficiency of hemostatic vitamin K-dependent protein activationR01HL158007 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI BERKNER, KATHLEEN LUCILE, RUNGE, KURT W · 2021 to 2024
$2.2M
Regulation of lifespanR01AG051601 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI RUNGE, KURT W · 2016 to 2020
$1.6M
NCATS NIH HHS UL1 TR002548NHLBI NIH HHS R01 HL055666NHLBI NIH HHS R01 HL081093NHLBI NIH HHS R01 HL158007NIA NIH HHS R01 AG051601
6 · The paper itself

Abstract

Essentials A carboxylase mutation that impairs splicing to delete exon 2 sequences was previously reported. We found that the mutant was inactive for vitamin K-dependent (VKD) protein carboxylation. An incomplete splicing defect likely accounts for VKD clotting activity observed in the patient. The results indicate the importance of proper carboxylase embedment in the membrane for function.

backgroundMutations in the γ-glutamyl carboxylase (GGCX), which is required for vitamin K-dependent (VKD) protein activation, can result in vitamin K clotting factor deficiency (VKCFD1). A recent report described a VKCFD1 patient with a homozygous carboxylase mutation that altered splicing and deleted exon 2 (Δ2GGCX). Only Δ2GGCX RNA was observed in the patient.

objectivesLoss of exon 2 results in the deletion of carboxylase sequences thought to be important for membrane topology and consequent function. Carboxylase activity is required for life, and we therefore tested whether the Δ2GGCX mutant is active.

methodsHEK 293 cells were edited by the use of CRISPR-Cas9 to eliminate endogenous carboxylase. Recombinant wild-type GGCX and recombinant Δ2GGCX were then expressed and tested for carboxylation of the VKD protein factor IX. A second approach was used to monitor carboxylation biochemically, using recombinant carboxylases expressed in insect cells that lack endogenous carboxylase. RESULTS AND

conclusionsΔ2GGCX activity was undetectable in both assays, which is strikingly different from the low levels of carboxylase activity observed with other VKCFD1 mutants. The similarity in clotting function between patients with Δ2GGCX and these mutations must therefore arise from a novel mechanism. Low levels of properly spliced carboxylase RNA that produce full-length protein would not have been observed in the previous study. The results suggest that the splicing defect is incomplete. Δ2GGCX RNA has been detected in normal human liver, and has been designated carboxylase isoform 2; however, Δ2GGCX protein was not observed in normal human liver. The lack of activity and protein expression suggest that isoform 2 is not physiologically relevant to normal VKD protein carboxylation.

Indexed as

ExonsMutationRNA SplicingBlood CoagulationBlood Coagulation Disorders, InheritedCarbon-Carbon LigasesCRISPR-Cas SystemsFactor IXGene EditingGenetic Predisposition to DiseaseHEK293 CellsHomozygoteHumansPhenotypeProtein Processing, Post-TranslationalCarbon-Carbon LigasesFactor IXglutamyl carboxylaseblood coagulation disordersCRISPR-Casinheritedvitamin KVKCFD1γ-glutamyl carboxylase

Identifiers

PMID31009158
PMCPMC7181818
OpenAlexW2941272803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.